Literature DB >> 19751435

A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation.

Louisa Jackson1, John Britton, Sarah A Lewis, Tricia M McKeever, John Atherton, Donna Fullerton, Andrew W Fogarty.   

Abstract

BACKGROUND: Infection with Helicobacter pylori is associated with a variety of non-gastrointestinal sequelae. These may be mediated by an increase in systemic inflammation. We assessed if serologic evidence of infection with H. pylori is associated with increased serum C-reactive protein (CRP) levels.
METHODS: The study design consisted of a randomly selected, cross-sectional population-based study of 2633 individuals phenotyped in 1991, of whom 2361 participants provided serum samples to permit measurement of H. pylori's serologic status and CRP levels.
RESULTS: Male gender (odds ratio (OR): 1.65; 95% confidence interval (CI): 1.23-2.21), age (OR per year: 1.05; 95% CI: 1.04-1.06), height (OR per meter: 0.05; 95% CI: 0.01-0.24), current smoking habit (compared with never smokers, OR: 1.46; 95% CI: 1.13-1.88), and less affluent socioeconomic status were associated with increased odds of being seropositive for H. pylori. Helicobacter pylori infection was associated with increased risk of having an elevated serum CRP (above 3 mg/L) after adjustment for gender, age, height, smoking status, and socioeconomic status (OR: 1.32; 95% CI: 1.05-1.67). Similar associations were seen using a threshold for elevated serum CRP of greater than 1 mg/L.
CONCLUSIONS: Our data suggest that infection with H. pylori is associated with increased systemic inflammation. This suggests one potential mechanism to explain the extra-gastrointestinal conditions associated with H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751435     DOI: 10.1111/j.1523-5378.2009.00711.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  36 in total

Review 1.  Role of aspirin in cancer prevention.

Authors:  Mangesh A Thorat; Jack Cuzick
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Serum hsCRP and procalcitonin levels in dyspeptic patients infected with CagA-positive Helicobacter pylori.

Authors:  Bulur Oktay; Yeniova Abdullah Ozgur; Kucukazman Metin; Ata Naim; Asilturk Zeliha; Yıldız Mehmet; Kefeli Ayse; Basyigit Sebahat; Aktas Bora; Nazlıgul Yasar
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

Review 3.  Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases.

Authors:  Mislav Radić
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women.

Authors:  Hui-Lee Wong; Charles S Rabkin; Xiao-Ou Shu; Ruth M Pfeiffer; Qiuyin Cai; Bu-Tian Ji; Gong Yang; Hong-Lan Li; Nathaniel Rothman; Yu-Tang Gao; Wei Zheng; Wong-Ho Chow
Journal:  Cancer Sci       Date:  2011-08-10       Impact factor: 6.716

Review 5.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32.

Authors:  Shoumin Zhu; Mohammed Soutto; Zheng Chen; DunFa Peng; Judith Romero-Gallo; Uma S Krishna; Abbes Belkhiri; M Kay Washington; Richard Peek; Wael El-Rifai
Journal:  Gut       Date:  2016-09-02       Impact factor: 23.059

7.  A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study.

Authors:  Lars E Bartels; Alma B Pedersen; Nickolaj R Kristensen; Hendrik Vilstrup; Kristian Stengaard-Pedersen; Jens F Dahlerup
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 8.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 9.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

10.  Impact of Helicobacter pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy.

Authors:  A S Hanafy; A T El Hawary; E F Hamed; A M Hassaneen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-14       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.